Antidiabetic agent 6

Antidiabetic agent 6 is a research compound that activates the PI3K/AKT pathway to stimulate GLUT4 translocation. It has demonstrated efficacy in reducing blood glucose levels in streptozotocin-induced diabetic rat models, supporting its use in diabetes research involving both cellular signaling and in vivo metabolic studies.